Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a traditional chinese herb ease PMS symptoms?

NCT ID NCT07171814

Symptom relief Sponsor: Lianxin Wang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will look at whether Honghua Xiaoyao tablets, a traditional Chinese medicine, can help relieve symptoms of premenstrual syndrome (PMS) in 266 women aged 18 to 40. The researchers will track symptom changes using a daily diary and compare women who take the tablets to those who don't. The goal is to see if the treatment reduces common PMS issues like mood swings, fatigue, and pain.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Honghua Xiaoyao tablet (a traditional Chinese medicine)
What this could lead to
If successful, this could provide a treatment option for women with premenstrual syndrome, potentially easing symptoms like mood swings, fatigue, and pain.
What could go wrong
This is an observational study, not a randomized controlled trial, so results may be less reliable. The study hasn't started yet, and the treatment is a traditional medicine with limited prior evidence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 266 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The somatic symptoms included headache, abdominal distension, limb swelling, breast pain, and insufficient motor coordination. Mental symptoms included irritability, emotional instability, depression and anxiety, changes in sexual desire, physical fatigue, insomnia, and loss of appetite. Behavioral changes are characterized by inattention, accidents, criminality, and suicidal tendencies, and these symptoms disappear after menstruation. The diagnostic basis is that if the above physical, mental and behavioral changes occur repeatedly and periodically during the luteal phase and last for more than three menstrual cycles, premenstrual syndrome can be diagnosed.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age:18-40 years old (both ends included); 2. According to the 8th edition of "Obstetrics and Gynecology" (2014), patients diagnosed with premenstrual syndrome; 3. In accordance with the TCM syndrome differentiation standard of liver depression and qi stagnation. Exclusion Criteria: 1. those who were allergic to the ingredients and excipients of Honghua Xiaoyao tablet (exposure group); 2. In the non-exposed group, those receiving or planning to receive other targeted medications for PMS, such as serotonin reuptake inhibitors (SSRIs), hormones, etc.; 3. irregular menstrual cycle (menstrual cycle not within 28±7 days); 4. serious diseases of cardiovascular, cerebrovascular, hematopoietic system, liver and kidney, and malignant tumors; 5. pregnant or lactating women, or those who plan to become pregnant within 6 months; 6. patients with mental illness and alcohol or drug dependence; Patients with other complicated lesions were not eligible for this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Premenstrual syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

premenstrual tension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Premenstrual syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.